We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.84%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
GIA
326
Gateway Investment Advisers
Ohio
$8.85M +$3.45M +15,407 +72%
Calamos Advisors
327
Calamos Advisors
Illinois
$8.82M +$1.85M +8,265 +29%
WAM
328
World Asset Management
Michigan
$8.77M +$2.86M +12,778 +54%
SSWM
329
Sheets Smith Wealth Management
North Carolina
$8.7M +$236K +1,053 +3%
Schroder Investment Management Group
330
Schroder Investment Management Group
United Kingdom
$8.69M +$3.78M +16,911 +89%
NMERB
331
New Mexico Educational Retirement Board
New Mexico
$8.51M +$2.81M +12,566 +55%
EAM
332
EULAV Asset Management
Florida
$8.37M +$224K +1,000 +3%
OC
333
Oppenheimer & Co
New York
$8.29M +$6.42M +28,680 +507%
BCM
334
Bridgeway Capital Management
Texas
$8.28M -$44.8K -200 -0.6%
WIC
335
Water Island Capital
New York
$8.25M -$13.5M -60,224 -64%
CIBC Asset Management
336
CIBC Asset Management
Ontario, Canada
$8.16M +$1.51M +6,752 +25%
B
337
BP
United Kingdom
$7.96M -$3.36M -15,000 -31%
SAM
338
Symphony Asset Management
California
$7.93M +$7.35M +32,864 New
Stifel Financial
339
Stifel Financial
Missouri
$7.93M +$4.45M +19,895 +154%
MLL
340
Moody Lynn & Lieberson
Massachusetts
$7.71M +$5.84M +26,097 +447%
CEP
341
Chicago Equity Partners
Illinois
$7.7M -$13.2M -58,916 -65%
FCM
342
Frontier Capital Management
Massachusetts
$7.59M -$104M -464,952 -94%
FTIOP
343
Fiduciary Trust International of Pennsylvania
Pennsylvania
$7.54M -$486K -2,172 -7%
BIM
344
Bridges Investment Management
Nebraska
$7.48M +$87.7K +392 +1%
GF
345
Gerry Farber
New York
$7.43M +$694K +3,100 +11%
RS
346
Robeco Schweiz
Switzerland
$7.33M +$1.13M +5,051 +20%
SC
347
Salzman & Co
New York
$7.33M
MCM
348
Maple Capital Management
Vermont
$7.24M +$139K +621 +2%
HVC
349
Healthcare Value Capital
New Jersey
$7.24M +$6.71M +30,000 New
MSE
350
MUFG Securities EMEA
United Kingdom
$7.24M +$6.71M +30,000 New

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.